This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Andrew Harding (businessman) | |
|---|---|
| Name | Andrew Harding |
| Nationality | British |
| Occupation | Businessman |
| Known for | Chief Executive Officer, GSK Consumer Healthcare joint venture |
Andrew Harding (businessman) Andrew Harding is a British businessman and pharmaceutical executive known for leadership roles in multinational healthcare and consumer goods companies. He has held senior positions at GlaxoSmithKline, GSK Consumer Healthcare, Novartis, and been involved with corporate governance across firms in the United Kingdom, United States, and Europe. Harding's career spans strategic integrations, mergers, and global commercial operations within the pharmaceutical industry, consumer health, and FMCG sectors.
Harding was born and raised in the United Kingdom and completed higher education at institutions connected with the United Kingdom. He studied business-related subjects before beginning a career in international commercial roles, with early professional experiences linked to organizations operating in Europe and North America. His formative education and training provided foundations for later executive roles at multinational corporations headquartered in London and Basel.
Harding's commercial career includes senior leadership at multinational corporations. He served in roles at GlaxoSmithKline with responsibilities spanning regional management and global product categories, contributing to interactions with teams in Philadelphia, Brentford, and other operational centers. Later moves included strategic posts at Novartis in Basel and consumer-facing assignments connected to assets in North America, Asia Pacific, and Latin America. His work encompassed portfolio management, mergers and acquisitions transactions, and integration projects linked to major deals involving Pfizer, Sanofi, and other industry players.
Throughout his career Harding engaged with regulatory, commercial, and supply chain stakeholders including regulators in the European Union, agencies in United States, and authorities across Asia. He participated in industry forums involving associations such as the International Federation of Pharmaceutical Manufacturers & Associations and networks tied to corporate governance frameworks in London Stock Exchange–listed groups. Harding's roles demanded coordination with investor relations teams, audit committees, and global marketing functions headquartered in cities like New York City, Basel, Tokyo, and Singapore.
At GlaxoSmithKline, Harding advanced to senior executive positions, assuming oversight of consumer health portfolios and joint-venture activities. He was instrumental in the creation and management of the GSK Consumer Healthcare joint venture, collaborating with senior leaders to align strategies across brands, supply operations, and regulatory filings. Harding worked alongside executives with experience at Johnson & Johnson, Procter & Gamble, and Reckitt Benckiser to integrate portfolios originating from transactions with Pfizer and other major firms.
Under his leadership Harding addressed commercial challenges in regions including Europe, Africa, and South America, coordinating launches and lifecycle management for brands competing in categories represented at trade events such as the Consumer Electronics Show and industry summits hosted by groups like the Consumer Healthcare Products Association. His tenure involved engagement with boards, shareholders on the London Stock Exchange, and coordination with legal teams in jurisdictions including United Kingdom, United States, and China to ensure compliance with competition authorities and intellectual property frameworks.
Beyond operational leadership Harding has served on boards and advisory councils for companies and organizations across sectors. He participated in governance discussions with firms listed on exchanges such as the London Stock Exchange and New York Stock Exchange, and advised corporations with activities in Europe, North America, and Asia Pacific. Harding contributed to advisory panels engaging with executives from Unilever, Nestlé, PepsiCo, and Coca-Cola on matters of consumer strategy, and engaged with private equity investors including firms like KKR, Bain Capital, and The Carlyle Group on sector trends.
He has been involved with industry trade bodies and business schools, providing guest lectures and mentorship linked to programs at institutions such as London Business School, Harvard Business School, and INSEAD. Harding's advisory roles connected him with leaders from McKinsey & Company, Boston Consulting Group, and Bain & Company on transformation and growth initiatives.
Harding received corporate and industry recognition for leadership in consumer healthcare and corporate integration. His teams earned accolades from trade organizations and media outlets covering pharmaceutical and consumer sectors, alongside acknowledgements from professional networks in London, New York City, and Basel. Industry commentators and business publications that cover executives at firms like GlaxoSmithKline, Novartis, and Pfizer have profiled his work on major transactions and operational turnarounds.
Harding lives in the United Kingdom with family ties to communities in Greater London and maintains residences compatible with his international work in Europe and North America. His personal interests include supporting charitable organizations and participating in mentorship initiatives associated with business schools and industry foundations.